ERBB2 and breast carcinoma: To examine the correlation between the expression level of the signature genes and the prognosis of HER2-positive breast cancer patients, we conducted survival analysis using the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) dataset (Table 3; Figure 5A,B).